Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Express Scripts
QuintilesIMS
Cipla
Merck
Fuji

Generated: September 16, 2019

DrugPatentWatch Database Preview

Patent: 8,940,698

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,940,698
Title:Cartilage material
Abstract: Cartilage materials such as cartilage fluff and a cartilage composition comprising a particulate material are disclosed. These are suitable for stimulating chondrogenesis and/or producing cartilage regeneration. Also disclosed are processes for their preparation. Methods for regenerating articular cartilage are also disclosed, which involve, for example, placing the cartilage fluff or cartilage composition into a cartilage defect.
Inventor(s): Malinin; Theodore I. (Key Biscayne, FL)
Assignee: Vivex Biomedical, Inc. (Marietta, GA)
Application Number:13/966,676
Patent Claims:see list of patent claims

Details for Patent 8,940,698

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23   Try a Free Trial Vivex Biomedical, Inc. (Marietta, GA) 2027-05-10 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   Try a Free Trial Vivex Biomedical, Inc. (Marietta, GA) 2027-05-10 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   Try a Free Trial Vivex Biomedical, Inc. (Marietta, GA) 2027-05-10 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23   Try a Free Trial Vivex Biomedical, Inc. (Marietta, GA) 2027-05-10 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 8,940,698

Country Patent Number Publication Date
United States of America 2008279825 Nov 13, 2008
United States of America 2011104242 May 05, 2011
United States of America 2013330391 Dec 12, 2013
United States of America 2014220096 Aug 07, 2014
United States of America 2014294911 Oct 02, 2014
United States of America 8791071 Jul 29, 2014
United States of America 8940692 Jan 27, 2015
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Cantor Fitzgerald
McKinsey
Mallinckrodt
Boehringer Ingelheim
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.